Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

Novo Nordisk has introduced Awiqli (insulin icodec) in India, the world's first once-weekly basal insulin, reducing annual ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...